OR WAIT null SECS
© 2022 MJH Life Sciences and Consultant Live. All rights reserved.
September 21, 2022
Simon Walsh, MD, and Elizabeth Estes join Lungcast to discuss advancements in biomarker and treatment option deliberation for the rare disease through data.
September 19, 2022
New EADV data suggest clinicians may need to uniquely treat patients with adult-onset eczema based on inflammatory pathways.
September 18, 2022
The approval is based on data from 2 clinical trials showing the agent improved the rate of post-operation patients avoiding sickness by 50%.
September 12, 2022
The novel OX40 inhibitor molecule showed significant benefit for patients in new EADV 2022 data. A lead author discusses its potential.